We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

231 hedge funds and large institutions have $1.72B invested in PDL BioPharma, Inc. in 2014 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 29

22% more capital invested

Capital invested by funds: $1.41B → $1.72B (+$311M)

4% more funds holding

Funds holding: 222 → 231 (+9)

10% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 71

34% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $5.79M

Holders
231
Holders Change
+9
Holders Change %
+4.05%
% of All Funds
6.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
78
Reduced
71
Closed
29
Calls
$3.82M
Puts
$5.79M
Net Calls
-$1.97M
Net Calls Change
-$4.08M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$21.5M
2
QI
QS Investors
New York
+$13.7M
3
HA
Hays Advisory
Tennessee
+$12.1M
4
Morgan Stanley
Morgan Stanley
New York
+$10.8M
5
Renaissance Technologies
Renaissance Technologies
New York
+$7.88M

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$15.9M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$11.3M
3
GAM
Gotham Asset Management
New York
-$7.09M
4
Invesco
Invesco
Georgia
-$5.22M
5
CIM
Calvert Investment Management
Maryland
-$4.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
76
Panagora Asset Management
Massachusetts
$1.69M -$146K -15,766 -7%
SCM
77
Sterling Capital Management
North Carolina
$1.58M +$1.96M +211,352 New
HighTower Advisors
78
HighTower Advisors
Illinois
$1.43M -$767K -82,638 -30%
Barclays
79
Barclays
United Kingdom
$1.41M -$8.76K -944 -0.5%
CCMH
80
Cornerstone Capital Management Holdings
New York
$1.33M -$1.55M -166,800 -48%
ARTA
81
A.R.T. Advisors
New York
$1.28M +$1.59M +170,879 New
Millennium Management
82
Millennium Management
New York
$1.23M +$1.52M +163,973 New
Swiss National Bank
83
Swiss National Bank
Switzerland
$1.18M -$26.9K -2,900 -2%
American Century Companies
84
American Century Companies
Missouri
$1.14M -$4.61M -497,038 -76%
ProShare Advisors
85
ProShare Advisors
Maryland
$1.13M -$281K -30,263 -17%
Asset Management One
86
Asset Management One
Japan
$1.12M -$2.33M -251,162 -63%
RhumbLine Advisers
87
RhumbLine Advisers
Massachusetts
$1.11M -$810K -87,200 -37%
CIP
88
Convergence Investment Partners
Florida
$1.09M – – –
State Board of Administration of Florida Retirement System
89
State Board of Administration of Florida Retirement System
Florida
$1.05M -$581K -62,622 -31%
AI
90
Atria Investments
North Carolina
$1.05M -$2M -215,278 -60%
SC
91
Scotia Capital
Ontario, Canada
$983K +$88.2K +9,497 +8%
SO
92
STRS Ohio
Ohio
$967K +$123K +13,200 +11%
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$952K -$41.3K -4,448 -3%
Tudor Investment Corp
94
Tudor Investment Corp
Connecticut
$940K +$699K +75,300 +149%
State of New Jersey Common Pension Fund D
95
State of New Jersey Common Pension Fund D
New Jersey
$934K – – –
CAM
96
ClariVest Asset Management
California
$865K -$966 -104 -0.1%
ACI
97
AMP Capital Investors
Australia
$860K – – –
UBS AM
98
UBS AM
Illinois
$825K +$144K +15,500 +16%
AL
99
Airain Ltd
Guernsey
$817K +$1.02M +109,403 New
PA
100
Profund Advisors
Maryland
$794K -$12.2K -1,314 -1%
2 3
4
5 6

PDLI Hedge Fund Activity: Q3 2014 in Review

231 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2014, worth a combined $1.72B — up 22% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new PDLI positions and 29 closed out — a net gain of 11 holders — while 78 added to existing stakes and 71 trimmed.

The largest buyer was Bank of America, adding an estimated $21.5M. The largest seller was Norges Bank, cutting an estimated $15.9M.

  • 231 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2014, up from 222 in Q2 2014.
  • Funds reported $1.72B of PDL BioPharma, Inc. stock for Q3 2014, up 22% quarter-over-quarter.
  • 40 funds opened new PDL BioPharma, Inc. positions in Q3 2014 and 29 closed out, a net change of +11 holders.
  • The largest PDL BioPharma, Inc. buyer in Q3 2014 was Bank of America, an estimated $21.5M added.
  • The largest PDL BioPharma, Inc. seller in Q3 2014 was Norges Bank, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2014.